Company research / QURE

uniQure N.V. (QURE)

CIK 0001590560 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, uniQure N.V. reported revenue of $16.10M. Revenue fell 40.6% from the prior annual period.

Key ratios (year ended 2025-12-31)

-1151.4%
Operating margin
-1236.0%
Net margin
-100.0%
Return on year-end equity
-40.6%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-09-02

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.